Skip to content
DraconiticResearch
Search Sources API
201,642 studies31 sourcesUpdated 14 min ago
Peer-reviewedLicence not statedJAMA Psychiatry

Interleukin 6 as a Treatment Target for Depression

  • Éimear M. Foley1,2
  • Nicholas L Turner3
  • Ruta Margelyte1,2
  • Hannah J Jones1,2,4
  • Muzaffer Kaşer5,6
  • Glyn Lewis7
  • Peter Brian Jones5,6
  • Golam Mohammed Khandaker8,1,2,4
8 affiliations
  1. 1Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
  2. 2MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
  3. 3Bristol Trials Centre, Bristol Medical School, University of Bristol, Bristol, United Kingdom
  4. 4NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
  5. 5Cambridgeshire and Peterborough NHS Trust, Cambridge, United Kingdom
  6. 6Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom
  7. 7Division of Psychiatry, University College London, London, United Kingdom
  8. 8Avon and Wiltshire Mental Health Partnership NHS Trust, Bristol, United Kingdom
Open at sourceDOICite

Related

  1. Proximity to an SGC–DLPFC individualized functional target and electric-field modeling do not predict clinical outcomes of rTMS for treatment-resistant depression
    Elizabeth Gregory, Shan Siddiqi, Michael Fox +5
    Brain stimulationPeer-reviewedCC BY-NC-NDFull text6 citedNeurologyOpenAlex
  2. Speech markers of depression: cross-sectional discrimination, longitudinal association, and treatment response prediction
    K. C. Moon, L. Behbehani, A. Malhotra +2
    medRxivPreprintAll rights reservedFull textPsychiatry & mental healthmedRxiv
  3. Lurasidone Induced Amphibian Like Buccal Oscillations: A Rare Case of Early Onset Tardive Dyskinesia Like Disorder in a Geriatric Patient with Treatment-Resistant Depression
    Ravi Chand Sharma, Ramanpreet Kaur
    Psychopharmacology BulletinPeer-reviewedLicence not statedFull textPsychiatry & mental healthPMC
  4. Examining the Relationship Between Perceived Social Satisfaction, Depression, and Anxiety for People With Multiple Sclerosis Participating in Group Treatment Modalities
    Brianne Markley, Nicholas R. Thompson, Grace Tworek +1
    International Journal of MS CarePeer-reviewedLicence not statedFull textGeneral medicinePMC
  5. Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression
    David Feifel, Mathieu Seynaeve, Wiesław Jerzy Cubała +12
    JAMAPeer-reviewedLicence not statedFull text1 citedPsychiatry & mental healthPMC

Cite

BibTeXRIS
BibTeX
@article{foley2026interleukin,
  title = {{Interleukin 6 as a Treatment Target for Depression}},
  author = {Éimear M. Foley and Nicholas L Turner and Ruta Margelyte and Hannah J Jones and Muzaffer Kaşer and Glyn Lewis and Peter Brian Jones and Golam Mohammed Khandaker},
  journal = {JAMA Psychiatry},
  year = {2026},
  month = may,
  doi = {10.1001/jamapsychiatry.2026.1053},
  url = {https://pubmed.ncbi.nlm.nih.gov/42160062/},
}
RIS
TY  - JOUR
TI  - Interleukin 6 as a Treatment Target for Depression
AU  - Éimear M. Foley
AU  - Nicholas L Turner
AU  - Ruta Margelyte
AU  - Hannah J Jones
AU  - Muzaffer Kaşer
AU  - Glyn Lewis
AU  - Peter Brian Jones
AU  - Golam Mohammed Khandaker
PY  - 2026
DA  - 2026/05/20
JO  - JAMA Psychiatry
DO  - 10.1001/jamapsychiatry.2026.1053
UR  - https://pubmed.ncbi.nlm.nih.gov/42160062/
SN  - 2168-622X
SN  - 2168-6238
ER  -